Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;7(1):17-27.
doi: 10.1007/s40121-017-0183-9. Epub 2017 Dec 22.

Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review

Affiliations
Review

Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review

Matteo Bassetti et al. Infect Dis Ther. 2018 Mar.

Abstract

Invasive aspergillosis (IA) is a serious opportunistic infection, which has increasingly been recognized as an emerging disease of non-neutropenic patients. In this group of patients, the diagnosis of IA can be challenging owing to the lack of specificity of symptoms, the difficulty in discriminating colonization from infection, and the lower sensitivity of microbiological and radiological tests compared with immunocompromised patients. The aim of this article is to present to clinicians a critical review on the management of IA in non-neutropenic patients.

Keywords: Aspergillus; Biomarkers; Galactomannan; Invasive aspergillosis; Liver cirrhosis; Non-neutropenic patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diagnostic and therapeutic approach in non-neutropenic patients with suspected IA

References

    1. Garcia-Vidal C, Peghin M, Cervera C, et al. Causes of death in a contemporary cohort of patients with invasive aspergillosis. PLoS One. 2015;10:e0120370. doi: 10.1371/journal.pone.0120370. - DOI - PMC - PubMed
    1. Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170:621–625. doi: 10.1164/rccm.200401-093OC. - DOI - PubMed
    1. Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and non-neutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43:577–584. doi: 10.1086/505870. - DOI - PubMed
    1. Perfect JR. The impact of the host on fungal infections. Am J Med. 2012;125:S39–S51. doi: 10.1016/j.amjmed.2011.10.010. - DOI - PubMed
    1. Patterson TF, Thompson GR, 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63:e1–e60. doi: 10.1093/cid/ciw326. - DOI - PMC - PubMed

LinkOut - more resources